Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab in Osteogenesis Imperfecta Biotech Investing
neffy® Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions Life Science Investing
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar Life Science Investing
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 Life Science Investing
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements Life Science Investing
Cizzle Brands Corporation Announces Closing of Transformative Transaction with the Acquisition of Flow Water Inc.'s Co-Manufacturing Business Biotech Investing
